Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Vergouwen

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|August 26, 1998
Packed-cell volume in elite athletesJ J Marx, P C Vergouwen
International Journal of Sports Medicine|December 22, 1999
Haematocrit in elite athletesP C Vergouwen, T Collée, J J Marx
Retinal Cases & Brief Reports|September 14, 2023
PARADOXICAL EXACERBATION OF SCLEROUVEITIS AFTER RITUXIMAB INFUSIONDaphne P C Vergouwen, Maud A W Hermans, Lise Sels
Ocular Immunology and Inflammation|February 5, 2021
Recurrences of Scleritis after Ocular SurgeryD P C Vergouwen, J C Ten Berge, A Rothova
Ocular Immunology and Inflammation|February 16, 2022
Subconjunctival Rituximab Administration for the Treatment of ScleritisD P C Vergouwen, J C Ten Berge, N C Naus-Postema, et al.
Ocular Immunology and Inflammation|August 31, 2021
Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious ScleritisD P C Vergouwen, J C Ten Berge, S Boukhrissi, et al.
Acta Ophthalmologica|June 14, 2021
Efficacy and maintenance of rituximab treatment in non-infectious scleritisDaphne P C Vergouwen, Jan A M van Laar, Josianne C Ten Berge, et al.
Frontiers in Ophthalmology|July 10, 2024
Scleritis in rheumatoid arthritis: Before and during biologic eraDaphne P C Vergouwen, Pascal H P de Jong, Marco W J Schreurs, et al.
Experimental Eye Research|June 7, 2020
Current insights in the pathogenesis of scleritisD P C Vergouwen, A Rothova, J C Ten Berge, et al.
Acta Ophthalmologica|December 23, 2023
Assessment of conjunctival, episcleral and scleral thickness in healthy individuals using anterior segment optical coherence tomographyG J Teeuw, D P C Vergouwen, W D Ramdas, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|August 26, 1998
Packed-cell volume in elite athletesJ J Marx, P C Vergouwen
International Journal of Sports Medicine|December 22, 1999
Haematocrit in elite athletesP C Vergouwen, T Collée, J J Marx
Retinal Cases & Brief Reports|September 14, 2023
PARADOXICAL EXACERBATION OF SCLEROUVEITIS AFTER RITUXIMAB INFUSIONDaphne P C Vergouwen, Maud A W Hermans, Lise Sels
Ocular Immunology and Inflammation|February 5, 2021
Recurrences of Scleritis after Ocular SurgeryD P C Vergouwen, J C Ten Berge, A Rothova
Ocular Immunology and Inflammation|February 16, 2022
Subconjunctival Rituximab Administration for the Treatment of ScleritisD P C Vergouwen, J C Ten Berge, N C Naus-Postema, et al.
Ocular Immunology and Inflammation|August 31, 2021
Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious ScleritisD P C Vergouwen, J C Ten Berge, S Boukhrissi, et al.
Acta Ophthalmologica|June 14, 2021
Efficacy and maintenance of rituximab treatment in non-infectious scleritisDaphne P C Vergouwen, Jan A M van Laar, Josianne C Ten Berge, et al.
Frontiers in Ophthalmology|July 10, 2024
Scleritis in rheumatoid arthritis: Before and during biologic eraDaphne P C Vergouwen, Pascal H P de Jong, Marco W J Schreurs, et al.
Experimental Eye Research|June 7, 2020
Current insights in the pathogenesis of scleritisD P C Vergouwen, A Rothova, J C Ten Berge, et al.
Acta Ophthalmologica|December 23, 2023
Assessment of conjunctival, episcleral and scleral thickness in healthy individuals using anterior segment optical coherence tomographyG J Teeuw, D P C Vergouwen, W D Ramdas, et al.
Pageof 2